🇺🇸 FDA

Drug profile · INN

pyridostigmine bromide

MESTINON

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

pyridostigmine bromide (MESTINON) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN pyridostigmine bromide
Brand MESTINON
Route INJECTION
Formulation TABLET, EXTENDED RELEASE

Frequently asked questions

What is pyridostigmine bromide?

pyridostigmine bromide (MESTINON) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for pyridostigmine bromide?

MESTINON is a marketed brand name for pyridostigmine bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pyridostigmine bromide?

pyridostigmine bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.